Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure
How to buy Avid Bioservices stock
Learn how to easily invest in Avid Bioservices stock.
Avid Bioservices Inc is a biotechnology business based in the US. Avid Bioservices shares (CDMO) are listed on the NASDAQ and all prices are listed in US Dollars. Avid Bioservices employs 252 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in Avid Bioservices
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – CDMO – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
Avid Bioservices stock price (NASDAQ: CDMO)Use our graph to track the performance of CDMO stocks over time.
Avid Bioservices shares at a glance
|Latest market close||$17.78|
|52-week range||$13.35 - $34.51|
|50-day moving average||$27.55|
|200-day moving average||$24.65|
|Wall St. target price||$32.67|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$0.14|
Buy Avid Bioservices shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Avid Bioservices stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Avid Bioservices price performance over time
|1 week (2022-01-15)||N/A|
|1 month (2021-12-22)||N/A|
|3 months (2021-10-22)||N/A|
|6 months (2021-07-26)||-29.14%|
|1 year (2021-01-26)||26.19%|
|2 years (2020-01-24)||157.68%|
|3 years (2019-01-25)||342.29%|
|5 years (2017-01-26)||5,779.63%|
Is Avid Bioservices stock undervalued or overvalued?
Valuing Avid Bioservices stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Avid Bioservices's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Avid Bioservices's P/E ratio
Avid Bioservices's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 134x. In other words, Avid Bioservices shares trade at around 134x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Avid Bioservices's EBITDA
Avid Bioservices's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $20.2 million.
The EBITDA is a measure of a Avid Bioservices's overall financial performance and is widely used to measure a its profitability.
Avid Bioservices financials
|Revenue TTM||$106.3 million|
|Operating margin TTM||15.39%|
|Gross profit TTM||$29.3 million|
|Return on assets TTM||4.92%|
|Return on equity TTM||27.91%|
|Market capitalisation||$1.1 billion|
TTM: trailing 12 months
Avid Bioservices share dividends
We're not expecting Avid Bioservices to pay a dividend over the next 12 months.
Have Avid Bioservices's shares ever split?
Avid Bioservices's shares were split on a 1:7 basis on 9 July 2017. So if you had owned 7 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Avid Bioservices shares – just the quantity. However, indirectly, the new 600% higher share price could have impacted the market appetite for Avid Bioservices shares which in turn could have impacted Avid Bioservices's share price.
Avid Bioservices share price volatility
Over the last 12 months, Avid Bioservices's shares have ranged in value from as little as $13.35 up to $34.51. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Avid Bioservices's is 2.2955. This would suggest that Avid Bioservices's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Avid Bioservices overview
Avid Bioservices, Inc. , a contract development and manufacturing organization, provides process development and current good manufacturing practices (CGMP) clinical and commercial manufacturing services focused on biopharmaceutical drug substances derived from mammalian cell culture. It produces monoclonal antibodies and recombinant proteins; and offers services, including CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing, and regulatory submission and support. The company also provides various process development services, such as upstream and downstream development and optimization, analytical methods development, testing, and characterization. It serves biotechnology and pharmaceutical companies. The company was formerly known as Peregrine Pharmaceuticals, Inc. and changed its name to Avid Bioservices, Inc.
Avid Bioservices in the news
The 1-Minute Market Report - January 25, 2022
Earnings playbook: A complete guide to this week's reports, including the first of tech
Avid Bioservices (CDMO) Stock Moves -1.67%: What You Should Know
Frequently asked questionsWhat percentage of Avid Bioservices is owned by insiders or institutions?
Currently 1.315% of Avid Bioservices shares are held by insiders and 96.244% by institutions. How many people work for Avid Bioservices?
Latest data suggests 252 work at Avid Bioservices. When does the fiscal year end for Avid Bioservices?
Avid Bioservices's fiscal year ends in April. Where is Avid Bioservices based?
Avid Bioservices's address is: 2642 Michelle Drive, Tustin, CA, United States, 92780 What is Avid Bioservices's ISIN number?
Avid Bioservices's international securities identification number is: US05368M1062 What is Avid Bioservices's CUSIP number?
Avid Bioservices's Committee on Uniform Securities Identification Procedures number is: 05368M106
More guides on Finder
How to buy Core Scientific stock
Steps to owning and managing CORZ, with 24-hour and historical pricing before you buy.
Walmart dives deep into the metaverse with crypto and NFTs
Walmart files trademarks with the goal to issue its own cryptocurrency and NFTs for use in its digital stores.
Melania Trump has an NFT — what to know before you buy
Melania Trump launched an NFT platform — you can buy an image of her eyes.
Vigorus (VIS) price prediction
Read our expert analysis on Vigorus and how the token will perform in the future.
Today’s top U.S. stocks: Mechel Pao ADRs (MTL ↑8.1%), Sibanye-Stillwater Limited (SBSW ↑7.4%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
How to order free at-home COVID tests today — but note, there’s a wait
Starting Jan. 18, every household can order up to four free at-home COVID-19 tests. But you’ll have to wait for them.
Today’s top U.S. stocks: Las Vegas Sands (LVS ↑15.3%), Wynn Resorts Limited (WYNN ↑9.1%)
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq.
Donut savings review
Donut earns up to 10% APY, but you must have an iOS device.
Monie savings review
Monie offers 5% APY on deposits, but funds aren’t insured and the interface is buggy.
Covid test stocks
We’ve rounded up stats on some of the most popular COVID test stocks, along with information on how they compare and how to invest.
Ask an Expert